by TractManager | Nov 22, 2019 | Clinical Utility Evaluation
This report evaluates the clinical utility of genetic screening of newborns for risk of hearing loss.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Nov 22, 2019 | Health Technology Assessment
Health Problem: Acute postoperative pain and swelling is common following orthopedic procedures. Inadequately controlled pain negatively affects quality of life and recovery of function and may result in an increase in morbidity, recovery time, opioid use, and risk of...
by TractManager | Nov 22, 2019 | Clinical Utility Evaluation
This report evaluates the clinical utility of genetic screening of newborns for risk of hearing loss.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Nov 21, 2019 | Emerging Technology Report
Givlaari is a subcutaneously administered ribonucleic acid interference (RNAi) agent that inhibits delta-aminolevulinate synthase 1 (ALAS1) synthesis, a key regulator of the heme biosynthetic pathway in the liver. Givlaari is believed to reduce ALAS1 levels, thereby...
by TractManager | Nov 21, 2019 | Health Technology Assessment
Health Problem: Plantar fasciitis (PF) is a progressive degenerative disorder of the plantar fascia, a fibrous band of tissue that runs along the bottom of the foot that connects the heel bone to each of the toes.Technology Description: Developments in how amniotic...
Recent Comments